Mouse Model and Protein Expression Core
小鼠模型和蛋白质表达核心
基本信息
- 批准号:8968256
- 负责人:
- 金额:$ 37.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至
- 项目状态:未结题
- 来源:
- 关键词:AnimalsAntibodiesAtherosclerosisBackcrossingsBiochemicalBiomedical ResearchEventFundingGenotypeGoalsHousingInbred StrainInstructionKnockout MiceMolecularMolecular and Cellular BiologyMonoclonal AntibodiesMouse ProteinMusObesityPathogenesisPlayProductionProgram Research Project GrantsProteinsProtocols documentationReagentRecombinant ProteinsRoleTechniquesTissuesTriglyceride MetabolismWorkembryonic stem cellexperiencehistological studieslipid biosynthesislipid metabolismmouse modelpolyclonal antibodyprotein expressionstructural biology
项目摘要
All three projects rely on genetically modified mice and the production of purified proteins and polyclonal and
monoclonal antibodies. Accordingly, all three projects will be supported by the Mouse Model and Protein
Expression Core (Core A), led by Dr. Loren Fong. Dr. Fong is an expert in a wide variety of practical
techniques in cellular and molecular biology, including growing and manipulating mouse embryonic stem
cells and the use of mouse models in biomedical research. This expertise has paid huge dividends for this
PPG. Dr. Fong, working with Drs. Reue, Young, and Tontonoz, has generated conventional and tissue-
specific Lipin2, Lipin3, Idol, and Tle3 knockout mice. In addition, the Core houses and genotypes mice,
backcrosses mice onto inbred strains, maintains animal protocols, and organizes histological studies on
mouse models.
The Core also produces purified proteins for biochemical studies and for generating polyclonal and
monoclonal antibodies; this has been an essential function, since our PPG has focused on newly discovered
molecules, for which few reagents exist. During the prior funding period, Drs. Bensadoun, Fong and Young
produced multiple antibody reagents for this PPG. Their expertise and experience will be a boon for the new
antibody projects proposed in this application. Aside from antibody reagents, the Core will also produce
purified recombinant proteins for biochemical and structural biology studies. All three projects of the PPG
will use Core A.
RELEVANCE (See instructions):
This Program Project Grant proposes to define the molecular mechanisms that regulate lipid metabolism and
adiposity-two events that play centrol roles in the pathogenesis of metablic disesase (e.g., obeisity and
atherosclerosis). The Mouse Model and Protein Expression Core will support the PPG's goals by providing
new mouse models, antibodies, and recombinant proteins to all three projects.
这三个项目都依赖于转基因小鼠和生产纯化蛋白和多克隆和
单克隆抗体。因此,所有三个项目都将得到老鼠模型和蛋白质的支持
Expression Core(核心A),由Loren Fong博士领导。方博士是各种实用领域的专家。
细胞和分子生物学技术,包括培养和操纵小鼠胚胎干细胞
细胞和小鼠模型在生物医学研究中的应用。这种专业知识为此付出了巨大的回报
PPG。方博士与Reue、Young和Tontonoz博士合作,创造了常规和组织-
特定的Lipin2、Lipin3、Idol和Tle3基因敲除小鼠。此外,核心房屋和基因型鼠,
将小鼠回交到近交系,维护动物规程,并组织对
老鼠模型。
核心还生产用于生化研究的纯化蛋白质,以及用于产生多克隆和
单抗;这是一个基本的功能,因为我们的PPG专注于新发现的
分子,这些分子的试剂很少。在之前的资助期间,Bensadoun博士、Fong和Young博士
为这种PPG生产了多种抗体试剂。他们的专业知识和经验将是新员工的福音
本申请中提出的抗体项目。除了抗体试剂,Core还将生产
用于生化和结构生物学研究的纯化重组蛋白。PPG的所有三个项目
将使用核心A。
相关性(请参阅说明):
该计划项目赠款建议定义调节脂质代谢的分子机制和
肥胖-在代谢性疾病发病机制中起中心作用的两个事件(例如,顺从和
动脉粥样硬化)。小鼠模型和蛋白质表达核心将通过提供
所有三个项目都有新的小鼠模型、抗体和重组蛋白。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Loren Gi Fong其他文献
Loren Gi Fong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Loren Gi Fong', 18)}}的其他基金
Imaging, Protein Production, and Chemical Biology Core
成像、蛋白质生产和化学生物学核心
- 批准号:
10161850 - 财政年份:2019
- 资助金额:
$ 37.26万 - 项目类别:
Imaging, Protein Production, and Chemical Biology Core
成像、蛋白质生产和化学生物学核心
- 批准号:
10613966 - 财政年份:2019
- 资助金额:
$ 37.26万 - 项目类别:
Imaging, Protein Production, and Chemical Biology Core
成像、蛋白质生产和化学生物学核心
- 批准号:
10397412 - 财政年份:2019
- 资助金额:
$ 37.26万 - 项目类别:
Development of a New Therapeutic Approach for Prelamin A Diseases
Prelamin A 疾病新治疗方法的开发
- 批准号:
9459813 - 财政年份:2014
- 资助金额:
$ 37.26万 - 项目类别:
Development of a New Therapeutic Approach for Prelamin A Diseases
Prelamin A 疾病新治疗方法的开发
- 批准号:
9027789 - 财政年份:2014
- 资助金额:
$ 37.26万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 37.26万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 37.26万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 37.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 37.26万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 37.26万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 37.26万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 37.26万 - 项目类别: